These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6377501)

  • 1. Conditioning regimens for marrow grafting.
    van Bekkum DW
    Semin Hematol; 1984 Apr; 21(2):81-90. PubMed ID: 6377501
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention and treatment of acute graft-versus-host disease.
    Neudorf S; Filipovich A; Ramsay N; Kersey J
    Semin Hematol; 1984 Apr; 21(2):91-100. PubMed ID: 6377502
    [No Abstract]   [Full Text] [Related]  

  • 3. Graft versus host disease prophylaxis today.
    Martelli MF; Aversa F
    Bone Marrow Transplant; 1991; 7 Suppl 2():112-6. PubMed ID: 1908726
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow transplantation for severe aplastic anaemia: cost/benefit of increased immunosuppression.
    Gordon-Smith EC
    Bone Marrow Transplant; 1991; 7 Suppl 2():103-5. PubMed ID: 1908725
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
    Ravinet A; Cabrespine A; Socié G; Milpied N; Yakoub Agha I; Nguyen S; Michallet M; Menard AL; Maillard N; Mohty M; Suarez F; Huynh A; Marchand T; Deteix C; Cassuto JP; Maury S; Chevallier P; Reman O; Peffault de Latour R; Bay JO
    Transplantation; 2016 Aug; 100(8):1732-9. PubMed ID: 26528768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation for aplastic anemia.
    Ramsay NK; Storb R
    Prog Clin Biol Res; 1984; 148():291-5. PubMed ID: 6379666
    [No Abstract]   [Full Text] [Related]  

  • 7. Late graft rejection following allogeneic bone marrow transplantation in aplastic anemia.
    Rodriguez V; Khan SP
    Transplant Proc; 2002 Jun; 34(4):1307-9. PubMed ID: 12072347
    [No Abstract]   [Full Text] [Related]  

  • 8. Patterns of graft rejection after bone marrow transplant in thalassemia.
    Galimberti M; Andreani M; Lucarelli G; Centis F; Filocamo M; Polchi P; Manenti F; Agostinelli F; Giorgi C; Filippetti A
    Prog Clin Biol Res; 1989; 309():223-9. PubMed ID: 2675090
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone marrow transplantation in acute nonlymphoblastic leukemia.
    Zwaan FE; Jansen J
    Semin Hematol; 1984 Jan; 21(1):36-42. PubMed ID: 6367055
    [No Abstract]   [Full Text] [Related]  

  • 10. New approaches for the prevention of rejection and graft-vs.-host disease in clinical bone marrow transplantation.
    Slavin S; Or R; Naparstek E; Cividalli G; Weshler Z; Weiss L; Mumcuoglu M; Engelhard D; Aker M; Pollack A
    Isr J Med Sci; 1986; 22(3-4):264-7. PubMed ID: 3528046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The graft-versus-host reaction.
    Seemayer TA; Gartner JG; Lapp WS
    Hum Pathol; 1983 Jan; 14(1):3-5. PubMed ID: 6219931
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone marrow transplantation (BMT) for thalassemia major (TM). The French experience.
    Frappaz D; Gluckman E; Souillet G; Maraninchi D; Demeocq F; Fischer A; Lutz P; Bergerat JP; Hervé P; Freycon F
    Prog Clin Biol Res; 1989; 309():207-16. PubMed ID: 2675088
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute graft-versus-host disease in thalassaemic marrow transplantation with low-dose antithymocyte globulin.
    Khojasteh HN; Zakerinia M; Ramzi M; Haghshenas M
    East Mediterr Health J; 1999 May; 5(3):465-9. PubMed ID: 10793825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of aplastic anemia.
    Gordon-Smith EC
    Prog Clin Biol Res; 1984; 148():335-41. PubMed ID: 6379671
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of three immunosuppressive regimens in high-risk patients: immunologic aspects.
    Renna Molajoni E; Bachetoni A; Cinti P; Sallustio F; Rossi M; Pretagostini R; Orlandini A; Berloco P; Alfani D; Cortesini R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1978-80. PubMed ID: 3079064
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of post-transplant methotrexate, cyclosporin A and prednisolone on graft rejection after allogeneic bone marrow transplantation.
    Uharek L; Gassmann W; Fleischhauer D; Wottge HU; Loeffler H; Mueller-Ruchholtz W
    Bone Marrow Transplant; 1991 Jan; 7(1):17-22. PubMed ID: 2043873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role of lymphocyte cytotoxicity in bone-marrow grafting.
    Oldham RK; Simmler MC
    Transplant Proc; 1974 Dec; 6(4):417-9. PubMed ID: 4280166
    [No Abstract]   [Full Text] [Related]  

  • 18. Marrow transplantation for the treatment of acute leukemia using HL-A-identical siblings.
    Buckner CD; Clift RA; Fefer A; Lerner KG; Neiman PE; Storb R; Thomas ED
    Transplant Proc; 1974 Dec; 6(4):365-6. PubMed ID: 4612892
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of immunosuppression on acute liver toxicity after intensified conditioning regimens for bone marrow transplantation in children.
    Emminger W; Emminger-Schmidmeier W; Peters C; Gadner H
    Blood; 1991 Apr; 77(7):1621. PubMed ID: 1844122
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia--the role of busulfan pharmacokinetics in determining outcome.
    Chandy M; Balasubramanian P; Ramachandran SV; Mathews V; George B; Dennison D; Krishnamoorthy R; Srivastava A
    Bone Marrow Transplant; 2005 Nov; 36(10):839-45. PubMed ID: 16151422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.